Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Sports playbook can help generate more accurate prognoses for cancer patients

Sports playbook can help generate more accurate prognoses for cancer patients

Multiple Sclerosis patients may have greater risk of developing cancer

Multiple Sclerosis patients may have greater risk of developing cancer

Study: One-fifth of hematological cancer patients suffer blood clots or bleeding

Study: One-fifth of hematological cancer patients suffer blood clots or bleeding

New findings could expand use of immunotherapy to fight cancers

New findings could expand use of immunotherapy to fight cancers

In secret, seniors discuss ‘rational suicide’

In secret, seniors discuss ‘rational suicide’

Unregulated pharmacy benefit manager practices may contribute to escalating expenses

Unregulated pharmacy benefit manager practices may contribute to escalating expenses

Chemotherapy can wreak havoc on the heart

Chemotherapy can wreak havoc on the heart

Cytek Biosciences unveils advanced five-laser flow cytometer

Cytek Biosciences unveils advanced five-laser flow cytometer

Research findings lead to new clinical trial for people with myelofibrosis

Research findings lead to new clinical trial for people with myelofibrosis

Henry Ford Cancer Institute treats its first patient with CAR T-cell therapy

Henry Ford Cancer Institute treats its first patient with CAR T-cell therapy

Heart failure drug could be effective in treating leukemia

Heart failure drug could be effective in treating leukemia

Disparities in race, ethnicity, and status affect progress in cancer survival rates in youth

Disparities in race, ethnicity, and status affect progress in cancer survival rates in youth

Researchers identify new sarcoma familial risk gene

Researchers identify new sarcoma familial risk gene

Study shows how SIRT1 plays key role in maintaining the regenerative potential of leukemic stem cells

Study shows how SIRT1 plays key role in maintaining the regenerative potential of leukemic stem cells

New tool reveals how genes interact to form tissues and organisms

New tool reveals how genes interact to form tissues and organisms

Georgetown University Medical Center announces launch of clinical trial for Lewy body dementia

Georgetown University Medical Center announces launch of clinical trial for Lewy body dementia

Blood stem cell breakthrough could spare some patients from side effects of cancer treatments

Blood stem cell breakthrough could spare some patients from side effects of cancer treatments

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Study identifies patterns of chronic lymphocytic leukemia growth

Study identifies patterns of chronic lymphocytic leukemia growth

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.